Oswald Lockhoff

This inventor holds 17 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Bayer Aktiengesellschaft, Troponwerke Gmbh & Co Kg. Active years: 1984-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oswald Lockhoff. Retrieved from https://idiyas.com/inventor/oswald-lockhoff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 5.7

ph-index = 7

Forward Citations = 130(Granted Patents)

Location History:

Cologne, DE (1986 - 1991)
Leverkusen, DE (1984 - 2000)

Company Filing History:

16 out of 12,269

Bayer Aktiengesellschaft

patents

1 out of 32

Troponwerke Gmbh & Co Kg

patents

Years Active: 1984-2000

Loading Chart...

Areas of Expertise:

Glycosylamides

Pharmaceutical Compounds

Dihydropyridines

Vascular Effects

N-glycosylated Ureas

Carbamates

O-acylglycosides

Growth-Promoters

Phosphorylated Compounds

Carboxylic Acid Derivatives

Substituted Glycosylamides

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6034055 - Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars (2000-03-07),

2. 5998448 - Combined preparations with vascular effect containing dihydropyridines (1999-12-07),

3. 5905071 - Glycosylamides of 2-aminoacylamino-2-deoxy sugars (1999-05-18),

4. 5859053 - Acetylsalicylic acid nitrates (1999-01-12),

5. 5070190 - Substituted N-glycosylamides, process for their preparation, and their (1991-12-03),

6. 4891425 - N-glycosylamide derivatives, processes for their preparation and their (1990-01-02),

7. 4855283 - Novel pharmaceutically active (1989-08-08),

8. 4737488 - Immune system-stimulating N-glycosylated ureas and carbamates (1988-04-12),

9. 4716152 - Pharmaceutical use of substituted O-acylglycosides (1987-12-29),

10. 4710491 - N-glycosylated carboxylic acid derivatives as agents for combating (1987-12-01),

11. 4699899 - Substituted O-sulphonyl-glycosylamides, processes for their preparation (1987-10-13),

12. 4686208 - Phosphorylated glycosyl-amides, -ureas, -carbamates and -thiocarbamates (1987-08-11),

13. 4683222 - N-glycosylated carboxamide derivatives and their use for influencing the (1987-07-28),

14. 4680287 - N-glycosylated carboxamide derivatives as growth-promoters in livestock (1987-07-14),

15. 4631272 - N-acylated 1-alkylamino-1-deoxy-ketose derivatives, a process for their (1986-12-23),

Title: The Innovator's Legacy: Oswald Lockhoff's Impact on Technology

Introduction

Oswald Lockhoff, a visionary inventor hailing from Cologne, Germany, has left an indelible mark on the world of innovation. With a total of 17 patents to his name, his unwavering passion for cutting-edge advancements continues to shape the landscape of technology.

Latest Patents

Lockhoff's latest patents include groundbreaking inventions such as Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars. This innovation opens new avenues in the realm of medicaments, offering unique compounds with immense potential for therapeutic applications. Additionally, his work on combined preparations with vascular effect containing dihydropyridines underscores his commitment to pioneering solutions in healthcare.

Career Highlights

Throughout his career, Lockhoff has made significant contributions while working at esteemed companies such as Bayer Aktiengesellschaft and Troponwerke GmbH & Co. Kg. His innovative spirit and dedication to excellence have propelled him to the forefront of the industry, earning him a reputation as a trailblazer in his field.

Collaborations

Collaborating with like-minded individuals such as Peter Stadler and Hans-Joachim Zeiler, Lockhoff has fostered a culture of innovation and knowledge-sharing. Together, they have pushed the boundaries of what is possible, inspiring a new generation of inventors to think boldly and creatively.

Conclusion

In conclusion, Oswald Lockhoff's remarkable journey as an inventor serves as a testament to the power of innovation and perseverance. His legacy will continue to inspire future generations to dream big, challenge the status quo, and revolutionize the world of technology.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]